Hidradenitis Suppurativa in Dermatology Research

Expect accelerated epigenetic aging in psoriatic arthritis, while psoriasis alone may not; signals are also seen in pediatric atopic dermatitis and...

A cohort study evaluated the use of glucagon-like peptide-1 receptor agonists in patients with hidradenitis suppurativa.

Several agents improved HiSCR-50 by 12–16 weeks vs placebo in adults with moderate to severe HS, with low SAE rates across groups; weekly adalimumab...

Pediatric HS often coexists with acne, obesity, and anxiety; screen for these and consider multidisciplinary care. Evidence for diabetes association...

Patients from lower-SES neighborhoods had higher adjusted odds of receiving a new HS diagnosis in this health system. Consider neighborhood context...

Do not rely solely on physician-rated severity or visibility to gauge impact. Routinely identify stigmatization and bullying and track change with...

For recalcitrant hidradenitis suppurativa, a 12–16-week home IV ertapenem course was linked to short-term improvements in symptoms and inflammatory...

Fewer than 60% of patients starting systemic immunomodulators received recommended baseline tests. Clinicians should verify TB and hepatitis...

For dermatology patients, short-term systemic JAK/TYK2 inhibitor use did not increase MACE or VTE versus placebo over a median 16 weeks. This...

A cross-sectional study comparing Crohn disease prevalence in US pediatric patients with vs without hidradenitis suppurativa.

No change in clinical practice. These preclinical data support continued clinical testing of oral orismilast as a selective PDE4 inhibitor with broad...